0001562180-24-000638.txt : 20240125
0001562180-24-000638.hdr.sgml : 20240125
20240125191702
ACCESSION NUMBER: 0001562180-24-000638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240123
FILED AS OF DATE: 20240125
DATE AS OF CHANGE: 20240125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quirk Erin
CENTRAL INDEX KEY: 0001843038
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39926
FILM NUMBER: 24563643
MAIL ADDRESS:
STREET 1: C/O TERNS PHARMACEUTICALS, INC.
STREET 2: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001831363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-525-5535 EXT.101
MAIL ADDRESS:
STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-01-23
false
0001831363
Terns Pharmaceuticals, Inc.
TERN
0001843038
Quirk Erin
C/O TERNS PHARMACEUTICALS, INC.
1065 EAST HILLSDALE BLVD., SUITE 100
FOSTER CITY
CA
94404
false
true
false
false
President, Head of R&D
false
Common Stock
2024-01-23
4
A
false
75000.00
0.00
A
75000.00
D
Stock Option (Right to Buy)
5.46
2024-01-23
4
A
false
150000.00
0.00
A
2034-01-22
Common Stock
150000.00
150000.00
D
Each share is represented by a Restricted Stock Unit ("RSU"). 25% of the RSUs vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.
25% of the shares subject to the option vest on the first anniversary measured from January 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
/s/ Bryan Yoon, as Attorney-in-Fact for Erin Quirk
2024-01-25